Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment

International Journal of Radiation Biology

Volumn 69, Issue 5, 1996, Pages 623-631

  Raaphorst, G P ^a   Wang, G ^a   Stewart, D ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; CARCINOMA CELL; DOSE RESPONSE; DRUG RESISTANCE; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIZATION;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG RESISTANCE; FEMALE; HUMANS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030013356     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096145634     Document Type: Article

References (37)

1. BEGG, A. C., 1990, Cisplatin and radiation: interaction probabilities and therapeutic possibilities. International Journal of Radiation Oncology, 19, 1183-1189
2. BEGG, A. C., VAN DER KOLK, P. L., DEWIT and BARTELINK, H., 1986, Radiosensitization by cisplatin of RIF1 tumour cells in vitro. International Journal of Radiation Oncology, 50, 871-884.
3. BRITTEN, R. A., WARENIUS, H. M., CARRAWAY, A. V. AND MURRAY D., 1994, Differential modulation of radiosensitivity following induction of cisplatin resistance in radiation-sensitive and radiation-resistant human cells. Radiation Oncology Investigations, 2, 25-31.
4. CARDE, P. and LAVAL, F., 1981, Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. International Journal of Radiation Oncology, 7, 929-933.
5. COUGHLIN, C. T. and RICHMOND, R. C., 1985, Platinum based combined modality approach for locally advanced head and neck carcinoma. International Journal of Radiation Oncology, 115, 915-919.
6. DA SILVA, V., CUTIN, P. H. HOFF, M. H. B., BERNSTEIN, M. A., DEEN, D. F. and WEAVER, K. A., 1984, The effect of combination treatment with cisplatin and low dose rate 125 I radiation in a murine brachytherapy model. International Journal of Radiation Oncology, 10, 1271-1472
7. DEWITT, L., 1987, Combined treatment of radiation and cis-diaminedichloroplatinum(II): a review of experimental and clinical data. International Journal of Radiation Oncology, 13, 403-426.
8. DEWITT, L., BARTELINK, H. and RUMKE, P. H., 1985, Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: a pilot study. Radiotherapy and Oncology, 3, 303-309.
9. DOUPLE, E. B., 1990, Antitumour drug-radiation interactions, Interaction between cisplatin coordination complexes and radiation, edited by B. T. Hill and A. S. Bellamy (Boca Raton: CRC Press), pp. 171-190.
10. DOUPLE, E. B., WILLS, M. L. and JONES, E., 1991, Concomitant Continuous Infusion Chemotherapy and Radiation (New York: Springer) pp. 191-196.
11. DRITSCHILO, A., PIRO, A. and KELMAN, A. D., 1979, The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. International Journal of Radiation Oncology,5, 1345-1349
12. DOUPLE, E. B. and RICHMOND, R. C., 1979, Radiosensitization of hypoxic tumour cells by cis-and trans-dichlordiammenplatium(II). International Journal of Radiation Oncology, Biology, Physics, 5, 1369-1372.
13. FU, K. K., RAYNER, P. A. and LAM K. N., 1984, Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion. International Journal of Radiation Oncology, 10, 1431-1478.
14. FU, K. K., LAM K. N. and RAYNER, P. A., 1985, The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (LDRI) on their combined effects on murine squamous cell carcinoma. International Journal of Radiation Oncology, 11, 2119-2124.
15. FU, K. K. LAM, K. N. and RAYNER, P. A., 1986, Effects of continuous low dose rate irradiation and concurrent infusion of mitomycin, cisplatin and 5 Flourouracil on three murine tumours. Endocurietherapy/Hyperthermia Oncology, 2, 157-162.
16. HAMILTON, T.C., LAI, G. M., ROTHENBERG, L. M., FOJO, A. T., YOUNG, R. C. and OZOLS, R. F. 1989, Drug Resistance in Cancer Therapy, Mechanisms of Resistance to Cisplatin and Alkylating Agents, (Boston:Kluwer), edited by R.F, OZOLS pp. 151-169.
17. HASELOW, R. E., ADAMS, G. S., OKEN, M. M., GOUDSMET, A., LERME, H. J. and MARSH, J.C., 1982, Simultaneous cisplatin (DDP) and radiation therapy for locally advance unresectable head and neck cancer. International Journal of Radiation Oncology, Biology, Physics, 8, 201.
18. KEIZER, H. J., KARIM, A. B.M. F., NJO, K. H., TIERIE, A. H., SNOW, G. B., VERMORKEN, J. B. and PINEDO, H. M. 1984. Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy. Radiotherapy and Oncology, 1, 227-234.
19. KORBELIK, M. and Ŝkov, K. A., 1989, Interaction of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research, 119, 145-156.
20. KUSKE, R. R., PEREZ, C. A., GRIGSBY, P. W., LOVETT, R. D., JACOBS, A. J., GALAKATOS, A. E., CAMEL, H. M. and KAO, M. S., 1989, Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. American Journal of Clinical Oncology, 12, 467-473.
21. LAI, G. M., OZOLS, R. F., SMYTH, J. F., YOUNG, R. C. and HAMILTON, T. C., 1988, Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochemical Pharmacology, 37, 4597-4600.
22. NIAS, A. H. W., 1985 Radiation and platinum drug interaction. International Journal of Radiation Biology, 48, 297-314.
23. OSHITA, F., FUJIWARA, Y., and SAIJO, N., 1992, Radiation sensitivities in various anticancer drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. Journal of Cancer Research and Clinical Oncology, 119, 28-34.
24. PIVER, M. S., 1981, OVARIAN CARCINOMA. A DECADE OF PROGRESS. Cancer, 54, 2706-2715.
25. POP, L., LOVENDAY, P., VAN GEEL, C., DEURLOO, I. K. and VISSER, A., 1992, Lack of therapeutic gain when low dose rate interstitial radiotherapy is combined with cisplatin in an animal tumour model. European Journal of Cancer, 28, 1471-1474.
26. RAAPHORST, G. P., FEELEY, M. M. DANJOUX, C. E., DA SILVA, V. and GERIGRM, L. H., 1991, Hyperthermia enhancement of radiation response and inhibition of recovery from radiation damage in human glioma cells. International Journal of Hyperthermia, 7, 629-641.
27. RAAPHORST, G. P., MAO, J. P. and NG, C. E., 1993, Repair of potentially lethal damage: its inhibition by hyperthermia in two melanoma cell lines with different radio- and heat sensitivities. Melanoma Research, 3, 351-356.
28. RAAPHORST, G. P., WANG, G. and NG, E., 1995, Radiosensitization by cisplatin treatment in cisplatin resistant and sensitive human ovarian carcinoma cell lines. International Journal of Oncology, 7, 325-330.
29. SCANLON, K. J., KASHANI-SABET, M., TONE, T. and FUNATO, T., 1991, Cisplatin resistance in human cancers. Pharmacological Therapy, 52, 385-406.
30. SCHWACHOFER, J. H. M., CROOIJMANS, R. P. M. A., HOOGENHOUT, J., KAL, H. B. and THEEUWES, A. G. M., 1991, Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. International Journal of Radiation Oncology, 20, 1235-1241.
31. SKOV, K. and MACPHAIL, S., 1991, Interaction of platinum drugs by clinically relevant x-ray doses in ammalian cells: a comparison of cisplatin, carboplatin,irroplatin and tetraplatin.. International Journal of Radiation Oncology, Biology, Physics, 20, 221-225
32. SLEDGE, G. W., 1992, Cisplatin and platinum analogues in breast cancer. Seminars in Oncology, 19, 78-82.
33. SZUMIEL, I. and NIAS, A. H. W., 1976, The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. British Journal of Cancer, 33, 450-458.
34. WALLNER, K. E. and LI G. C., 1987, Effect of cisplatin resistance on cellular radiation response. International Journal of Radiation Oncology, 13, 587-591.
35. WALTER, P., KORBELIK, M., SPADINGER, I. and SKOV, K., 1993, Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiation Oncology Investigations, 1, 137-147.
36. WILKINS, D. E., NG, C. E. and RAAPHORST, G. P., 1995, Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. International Journal of Radiation Oncology (submitted).
37. WILKINS, D. E., RAAPHORST, G. P. and HELLER, D.P., 1993, Inhibition of potentially lethal damage recovery by cisplatin in the 9L rat brain cell line. Anti Cancer Research, 13, 2137-2142.